Supplemental Experimental Procedures
Movie S1 -F/f pMECs form sprouts in the fibrin bead assay (linked to Figure 1 ). Frames are taken every 30min for 51h and displayed at 15 fps.
Movie S2 -Raf-1 Δ/Δ pMECS behaviour in the fibrin bead assay (linked to Figure 1 ). Note how tip cells break off the developing sprout. Frames are taken every 30min for 65.5h and displayed at 15 fps.
Figure S1 -Endothelial cell-restriced Raf-1 ablation does not affect tissue homeostasis but impairs vascular development of the retina (linked to Figure 1) . A, Tissue and blood vessel architecture is not affected in adult Raf-1 Δ/ΔEC animals. Organs were isolated from 8 weeks-old mice and stained with H&E to examine morphology or with CD31 (top panel, kidney) to visualize blood vessels. No differences in large vessel integrity or vascular density could be observed comparing f/f and Raf-1 Δ/ΔEC mice. B-D, Retinal vascularization is impaired in postnatal day 6 Raf-1 Δ/ΔEC mice. Preparation of the retina, quantification of the radial extension of the vascular plexus, vascular branching and number of filopodia was carried out as described (Pitulescu et al., 2010) . B, The progression of the angiogenic front toward the periphery is delayed in Raf-1 Δ/ΔEC compared to f/f mice. Development of the superficial vascular plexus in f/f and Raf-1 Δ/ΔEC mice is shown by tile-scanning, composite confocal pictures of individual fields taken with a ×10 lens. Whole mounts were stained with CD31 antibody to visualize endothelial cells. The graph shows the distance of the angiogenic front from the central optical nerve head in three f/f and four Raf-1 Δ/ΔEC retinas. C, Branching is compromised in Raf-1 Δ/ΔEC retinas. The image shows a capillary plexus area close to the edge of the angiogenic front and situated between an artery and a vein. The number of branching points/field (defined as junctions of capillary segments) was determined on images taken with a ×40 lens. One field covers 106113 µm 2 . D,The Raf-1 Δ/ΔEC angiogenic front contains increased numbers of ECs extending filopodia. The number of filopodia/mm angiogenic front was determined on a field covered by a x40 lens. E, Dispersed VEC localization in Raf-1 Δ/ΔEC tip cells. VEC localization is not significantly different in f/f and Raf-1 Δ/ΔEC established vessels (top panel), but fails to localize at the cell border in Raf-1 Δ/ΔEC tip cells (lower panel; 2 examples are shown). This phenotype was observed in 50±12% (n=6) Raf-1 Δ/ΔEC tip cells, and in <1% f/f cells (n=8). F, Single cell migration in 2D is not affected by Raf-1 ablation. Fifty thousand f/f or Raf-1 Δ/Δ iMECs were seeded on Boyden chambers (BD Falcon, 8μm pore size) in starvation medium and allowed to migrate for 4 hours towards 50 ng/ml VEGF or 50 ng/ml FGF or 5% FBS. After 4 hours at 37°C, cells on the lower membrane surface were fixed, stained and counted (at least 20 fields) using ImageJ software. G, Raf-1 is dispensable for Erk activation. iMECs were treated with FGF-2 (50 ng/ml, 30 min) and VEGF (50 ng/ml, 30 min) and Erk activation was determined by Immunoblotting with antibodies specific to phosphorylated Erk1/2. The numbers on top of the pERK panel represent a quantification of the intensity of the bands, normalized to the loading control. The value corresponding to untreated f/f cells arbitrarily defined as 1. Scale bars: A, 200 μm; B, 1 mm (upper panel), 500 μm (lower panel); C-E, 50 μm Figure 1) . A, Aortic explants isolated from Raf-1 Δ/ΔEC animals show dramatically reduced sprout formation. Aortic segment from f/f and Raf-1 Δ/ΔEC littermates were embedded in fibrin gels supplemented with VEGF (100 ng/ml) and FGF-2 (1 μg/ml) as previously described (Burbridge and West, 2001 ). Sprout formation was assessed microscopically after 5 days in culture. B, Cartoon showing the principles of the fibrin bead assay. C, Raf-1 deletion does not affect pMEC adhesion to microcarriers or proliferation in 3D fibrin gels. pMECs were incubated with Cytodex3 microcarriers (4-5 hrs), fixed and stained with DAPI. Similar numbers of flox/flox and Raf-1 Δ/Δ cells adhered to the beads. D, Raf-1 deletion does not affect pMEC proliferation in fibrin gels. Proliferating cells were detected by BrdU incorporation (4h BrdU prior to fixing and staining with an anti-BrdU antibody on day 2 and 3 (d2 and d3) of culture). At least 25 microcarriers were imaged and BrdU + cells were counted per genotype and day. Quantification of these results is shown in the bottom panel. Error bars represent the SD of the mean. E, Raf-1 Δ/Δ pMECs adopt a mesenchymal phenotype and migrate, but fail to form tubules in fibrin gels. IsolectinB4 staining (Vasudevan and Pradeep G, 2008) confirms that both the f/f and the Raf-1 Δ/Δ fibrin gel cultures contain exclusively pMECs. Note the mesenchymal morphology of the Raf-1 Δ/Δ pMECs. F-G, Normal proliferation (F) and survival (G) of Raf-1 Δ/Δ ECs in matrigel plugs. Mice bearing matrigel plugs were injected with BrdU (0.1mg BrdU/g) 2h before plug excision. Whole plugs were fixed and VEC (red) and BrdU (green) were visualized by immunofluorescence. DAPI was used as a counterstain. Apoptotic cells in the matrigel plug vessels were identfied by TUNEL (In Situ Cell Death Kit, Roche) and CD31 staining. CD31 counterstaining in the plugs was carried out as described in Methods. After the last PBS wash, plugs were digested with Proteinase K (5µg/ml in PBS, 20 min at RT), washed thrice (PBS, 5 min), and incubated with the TUNEL reaction mixture (2 hrs at 37°C) in a light-protected vial. Plugs were washed (PBS, 3 X 5 min at RT) and mounted. F-G, Quantification is shown as mean ± SE of 3 mice/genotype. Scale bars: A, 500 μm; C, 50 μm; D, 100 μm; E, 200 μm; F, 20 μm Figure S3 -Rok-β is not found at VEC containing AJ (linked to Figure 3 and Figure 5) . A, Rok-β does not co-Immunoprecipitate with VEC. iMECs were stimulated with FGF-2 (50 ng/ml, 30min) or 007 (50 μM, 30min) as indicated. VEC or Raf-1 immunoprecipitates were prepared and the presence of VEC or Raf-1 and co-immunoprecipitating proteins were detected by immunoblotting. B, Rok-β does not colocalize with VEC in AJ in the presence of FGF-2. iMECS were cultured for 24h in the presence of FGF-2 (50 ng/ml). Rok-β (red) and VEC (green) were visualized by confocal microscopy. DAPI was used as a counterstain. C, EPAC/Rap activation does not recruit Rok-β to VEC AJ. iMECs were plated for 2h in the presence or absence of 007 (250 μM). The distribution of Rok-β (red) and VEC (green) was analyzed by confocal microscopy. DAPI (blue) was used as a counterstain. Scale bars 20 μm. Figure S4 -AJ maturation and Rok-α localization to developing AJs are inhibited to comparable degrees by Rap1/B gene silencing and by the prenylation inhibitor GGTi298 (linked to Figure 6) . A, iMECS in which Rap1A and Rap1B were knocked down by siRNA interference or pretreated with GGTi298 (10 μM; 1.5h) as indicated were seeded for 2h in the presence or absence of 007 (250μM). Rok-α (red) and VEC (green) were visualized by confocal microscopy. DAPI (blue) was used as a counterstain. Junctional Rok-α was absent, and AJ maturation was impaired, in f/f cells lacking Rap1/B as well as in cells treated with GGTi298. The graph shows the percentage of cells with mature AJ (mean ± SD). B, Knock down efficiency is shown by immunoblotting. Scale bars: 20 μm. Figure 6 ). Sprouting is impaired by 007-mediated Rap1 activation as well as by Rap1 inhibition with GGTi298. The EPAC1 activator 007 (250 μM) or the Rap1 inhibitor GGTi298 (10 μM) were added to the fibrin gels. Sprout formation was analyzed after 3 days in culture. Sprouting efficiency was quantified as sprout length (left panel) and number of sprout/beads. A minimum of n=25 microcarriers per genotype and treatment were assessed. Error bars represent the SE of the mean.
